Yi Wang

Dr. Yi Wang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2021 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
MRManman Ren
Manman Ren
YZYa Zhao
Ya Zhao
ZHZhiqi He
Zhiqi He
JLJian Lin
Jian Lin
CXChuchu Xu
Chuchu Xu
YWYi Wang
Yi Wang
Background: Periodontitis is a chronic infection initiated by oral bacterial and their virulence factors, yet the severity of periodontitis is largely determined by the dysregulated host immuno-inflammatory response. Baicalein is a flavonoid extracted fromScutellaria baicalensiswith promising anti-inflammatory properties. This study aims to clarify the anti-inflammatory and osteogenic effects of baicalein in periodontal ligament cells (PDLCs) treated with lipopolysaccharides (LPS).Methods: Human PDLCs were incubated with baicalein (0–100 μM) for 2 h prior to LPS challenge for 24 h. MTT analysis was adopted to assess the cytoxicity of baicalein. The mRNA and protein expression of inflammatory and osteogenic markers were measured by real-time polymerase chain reaction (PCR), western blot and enzyme-linked immunosorbent assay (ELISA) as appropriate. Alkaline phosphatase (ALP) and Alizarin red S (ARS) staining were performed to evaluate the osteogenic differentiation of PDLCs. The expression of Wnt/β-catenin and mitogen-activated protein kinase (MAPK) signaling related proteins was assessed by western blot.Results: MTT results showed that baicalein up to 100 μM had no cytotoxicity on PDLCs. Baicalein significantly attenuated the inflammatory factors induced by LPS, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), matrix metalloprotein-1 (MMP-1), MMP-2 and monocyte chemoattractant protein 1 (MCP-1) at both mRNA and protein level. Moreover, MAPK signaling (ERK, JNK and p38) was significantly inhibited by baicalein, which may account for the mitigated inflammatory response. Next, we found that baicalein effectively restored the osteogenic differentiation of LPS-treated PDLCs, as shown by the increased ALP and ARS staining. Accordingly, the protein and gene expression of osteogenic markers, namely runt-related transcription factor 2 (RUNX2), collagen-I, and osterix were markedly upregulated. Importantly, baicalein could function as the Wnt/β-catenin signaling activator, which may lead to the increased osteoblastic differentiation of PDLCs.Conclusions: With the limitation of the study, we provide in vitro evidence that baicalein ameliorates inflammatory response and restores osteogenesis in PDLCs challenged with LPS, indicating its potential use as the host response modulator for the management of periodontitis.

5 August 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
YWYi Wang
Yi Wang
TCTengda Chu
Tengda Chu
YGYixuan Gong
Yixuan Gong
SLSisi Li
Sisi Li
LWLixia Wu
Lixia Wu
DHDeng Hui
Deng Hui
Purpose: The effect of hyperglycemia on periodontitis is mainly based on observational studies, and inconsistent results were found whether periodontal treatment favors glycemic control. The two-way relationship between periodontitis and hyperglycemia needs to be further elucidated. This study aims to evaluate the causal association of periodontitis with glycemic traits using bi-directional Mendelian randomization (MR) approach.Methods: Summary statistics were sourced from large-scale genome-wide association study conducted for fasting glucose (N = 133,010), HbA1c (N = 123,665), type 2 diabetes (T2D, N = 659,316), and periodontitis (N = 506,594) among European ancestry. The causal relationship was estimated using the inverse-variance weighted (IVW) model and further validated through extensive complementary and sensitivity analyses.Results: Overall, IVW showed that a genetically higher level of fasting glucose was significantly associated with periodontitis (OR = 1.119; 95% CI = 1.045–1.197; PFDR= 0.007) after removing the outlying instruments. Such association was robust and consistent through other MR models. Limited evidence was found suggesting the association of HbA1C with periodontitis after excluding the outliers (IVW OR = 1.123; 95% CI = 1.026–1.229; PFDR= 0.048). These linkages remained statistically significant in multivariate MR analyses, after adjusting for body mass index. The reverse direction MR analyses did not exhibit the causal association of genetic liability to periodontitis with any of the glycemic trait tested.Conclusions: Our MR study reaffirms previous findings and extends evidence to substantiate the causal effect of hyperglycemia on periodontitis. Future studies with robust genetic instruments are needed to confirm the causal association of periodontitis with glycemic traits.

29 April 2020 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
YWYi Wang
Yi Wang
HLHin Nam Liu
Hin Nam Liu
ZZZhe Zhen
Zhe Zhen
GPGeorge Pelekos
George Pelekos
MWMei Zhen Wu
Mei Zhen Wu
LJLijian Jin
Lijian Jin

20 September 2019 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
YWYi Wang
Yi Wang
BHBibo Hu
Bibo Hu
RHRongdang Hu
Rongdang Hu
XTXianqin Tong
Xianqin Tong
MZMenghan Zhang
Menghan Zhang
DHDeng Hui
Deng Hui

18 February 2021 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
YZYa Zhao
Ya Zhao
ZZZhiwei Zheng
Zhiwei Zheng
MZMenghan Zhang
Menghan Zhang
YWYi Wang
Yi Wang
RHRongdang Hu
Rongdang Hu
DHDeng Hui
Deng Hui

24 October 2017 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
YWYi Wang
Yi Wang
HLHin Nam Liu
Hin Nam Liu
ZZZhe Zhen
Zhe Zhen
KYKai Hang Yiu
Kai Hang Yiu
HTHung-Fat Tse
Hung-Fat Tse
LJLijian Jin
Lijian Jin